Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 May;38(5):2276-2302.
doi: 10.1002/ptr.8110. Epub 2024 Feb 29.

New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms

Shufen Han  1 , Yifei Cao  1 , Xingrong Wu  2 , Jiaoyang Xu  1 , Zizheng Nie  1 , Yue Qiu  1
Affiliations
Meta-Analysis

New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms

Shufen Han et al. Phytother Res. 2024 May.

Abstract

Saffron (Crocus sativus), as an herbal medicine, has been extensively investigated for treating neurological and psychiatric disorders. This systematic review aimed to assess the overall effects of saffron on cognition, depression, anxiety, sleep disorders, attention-deficit/hyperactivity disorder (ADHD), and obsessive-compulsive disorder (OCD). Relevant randomized controlled trials (RCTs) were identified by searching PubMed/Medline, Web of Science, and Clinical Trials databases up to June 2023 according to search terms and inclusion criteria. The participants were either healthy or suffering from some diseases, including neurological and psychiatric disorders, and consumed saffron or its extracts as an intervention. The risk of bias was assessed according to the Cochrane guidelines, and the PRISMA statement was followed. The meta-analysis was performed using RevMan and STATA software. A random-effects or fixed-effects model was used to calculate the pooled effect sizes. Forty-six RCTs were enrolled, and the duration of these trials ranged from 4 to 48 weeks with saffron or its extracts, both alone or in combination with conventional drugs. Saffron was more effective than placebo in improving cognition, depression with an overall effect size of -4.26 (95% CI: -5.76, -2.77), anxiety of -3.75 (95% CI: -5.83, -1.67), and sleep disorders of -1.91 (95% CI: -2.88, -0.93). Saffron was non-inferior to conventional drugs for treating cognitive disorders, depression, anxiety, ADHD, and OCD, and it exhibited good tolerance with few side effects. Saffron may exert protective roles for neurological and psychiatric disorders and represents a relatively favorable and safe treatment.

Keywords: ADHD; OCD; cognition; depression and anxiety; saffron; sleep disorders.

PubMed Disclaimer

References

REFERENCES

    1. Abbaszadeh‐Mashkani, S., Hoque, S. S., Banafshe, H. R., & Ghaderi, A. (2020). The effect of crocin (the main active saffron constituent) on the cognitive functions, craving, and withdrawal syndrome in opioid patients under methadone maintenance treatment. Phytotherapy Research, 35(3), 1486–1494.
    1. Abedimanesh, N., Ostadrahimi, A., Bathaie, S. Z., Abedimanesh, S., Motlagh, B., Jafarabadi, M. A., & Sadeghi, M. T. (2017). Effects of saffron aqueous extract and its main constituent, crocin, on health‐related quality of life, depression, and sexual desire in coronary artery disease patients: A double‐blind, placebo‐controlled, randomized clinical trial. Iranian Red Crescent Medical Journal, 19(9), e13676.
    1. Agha‐Hosseini, M., Kashani, L., Aleyaseen, A., Ghoreishi, A., Rahmanpour, H., Zarrinara, H. R., & Akhondzadeh, S. (2008). Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: A double‐blind, randomised and placebo‐controlled trial. BJOG, 115(4), 515–519.
    1. Ahmad, S., Azhar, A., Tikmani, P., Rafique, H., Khan, A., Mesiya, H., & Saeed, H. (2022). A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti‐inflammatory responses in depressive patients. Heliyon, 8(10), e10774.
    1. Ahmadpanah, M., Ramezanshams, F., Ghaleiha, A., Akhondzadeh, S., Bahmani, D. S., & Brand, S. (2019). Crocus sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders‐a double‐blind, randomized intervention study. Psychiatry Research, 282, 112613.

MeSH terms

LinkOut - more resources